{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:37:46Z","timestamp":1791041866342,"version":"4.1.0"},"reference-count":0,"publisher":"Harborside Press, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Natl Compr Canc Netw"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.6004\/jnccn.2015.0012","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T12:05:59Z","timestamp":1492171559000},"page":"109-117","source":"Crossref","is-referenced-by-count":31,"title":["Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors"],"prefix":"10.6004","volume":"13","author":[{"given":"Sujata","family":"Narayanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","published-online":{"date-parts":[[2015,1,12]]},"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T12:11:14Z","timestamp":1551701474000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/doi\/10.6004\/jnccn.2015.0012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,12]]},"published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.6004\/jnccn.2015.0012"],"URL":"https:\/\/doi.org\/10.6004\/jnccn.2015.0012","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}